Endothelin receptor in virus-like particles: Ligand binding observed by fluorescence fluctuation spectroscopy

Biochemistry

Volumn 43, Issue 28, 2004, Pages 9021-9028

  Zemanová, Lenka ^a   Schenk, Andreas ^a   Hunt, Nicholas ^b   Nienhaus, G Ulrich ^a,c   Heilker, Ralf ^d  

^a UNIVERSITY OF ULM   (Germany)

^b EVOTEC UK LTD   (United Kingdom)

^c University of Illinois at Urbana Champaign   (United States)

^d B Ingelheim Pharma GmbH/Co KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CELL CULTURE; CHEMICAL BONDS; PROTEINS; SPECTROSCOPIC ANALYSIS; VIRUSES;

FLUORESCENCE CORRELATION SPECTROSCOPY; TRANSMEMBRANE RECEPTOR PROTEINS;

BIOCHEMISTRY;

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR; RECEPTOR PROTEIN; RHODAMINE;

ARTICLE; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE FLUCTUATION SPECTROSCOPY; FLUORESCENCE SPECTROSCOPY; LIGAND BINDING; LIPID BILAYER; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR BINDING; RECEPTOR DENSITY; VIRUS PARTICLE;

CELL LINE; CELL MEMBRANE; ENDOTHELIN-1; FLUORESCENT DYES; HUMANS; LIGANDS; MODELS, THEORETICAL; PROTEIN BINDING; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SPECTROMETRY, FLUORESCENCE; TITRIMETRY; TRANSFECTION; VIRION;

MAMMALIA;

EID: 3142707949     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi035901+     Document Type: Article

References (38)

1. Drews, J. (2000) Drug discovery: a historical perspective, Science 287, 1960-1964.
2. Ma, P., and Zemmel, R. (2002) Value of novelty?, Nat. Rev. Drug Discov. 1, 571-572.
3. Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., and De Wilde, M. (1989) Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells, Cell 59, 103-112.
4. Hughes, B. P., Booth, T. F., Belyaev, A. S., McIlroy, D., Jowett, J., and Roy, P. (1993) Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells, Virology 193, 242-255.
5. Morikawa, S., Booth, T. F., and Bishop, D. H. (1991) Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors, Virology 183, 288-297.
6. Royer, M., Cerutti, M., Gay, B., Hong, S. S., Devauchelle, G., and Boulanger, P. (1991) Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells, Virology 184, 417-422.
7. Zhou, W., Parent, L. J., Wills, J. W., and Resh, M. D. (1994) Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids, J. Virol. 68, 2556-2569.
8. Yamshchikov, G. V., Ritter, G. D., Vey, M., and Compans, R. W. (1995) Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system, Virology 214, 50-58.
9. Delchambre, M., Gheysen, D., Thines, D., Thiriart, C., Jacobs, E., Verdin, E., Horth, M., Burny, A., and Bex, F. (1989) The GAG precursor of simian immunodeficiency virus assembles into virus-like particles, EMBO J. 8, 2653-2660.
10. Luo, L., Li, Y., and Kang, C. Y. (1990) Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells, Virology 179, 874-880.
11. Bremnes, T., Paasche, J. D., Mehlum, A., Sandberg, C., Bremnes, B., and Attramadal, H. (2000) Regulation and intracellular trafficking pathways of the endothelin receptors, J. Biol. Chem. 275, 17596-17604.
12. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411-415.
13. Hosoda, K., Nakao, K., Tamura, N., Arai, H., Ogawa, Y., Suga, S., Nakanishi, S., and Imura, H. (1992) Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor, J. Biol. Chem. 267, 18797-18804.
14. Aragon, S. R., and Pecora, R. (1975) Fluorescence correlation spectroscopy and Brownian rotational diffusion, Biopolymers 14, 119-137.
15. Elson, E. L., and Madge D. (1974) Fluorescence Correlation Spectroscopy, I: Conceptual Basis and Theory, Biopolymers 13, 1-27.
16. Lamb, D. C., Schenk, A., Rocker, C., Scalfi-Happ, C., and Nienhaus, G. U. (2000) Sensitivity enhancement in fluorescence correlation spectroscopy of multiple species using time-gated detection, Biophys. J. 79, 1129-1138.
17. Chen, Y., Muller, J. D., So, P. T., and Gratton, E. (1999) The photon counting histogram in fluorescence fluctuation spectroscopy, Biophys. J. 77, 553-567.
18. Kask, P., Palo, K., Ullmann, D., and Gall, K. (1999) Fluorescence- intensity distribution analysis and its application in biomolecular detection technology, Proc. Natl. Acad. Sci. U. S. A 96, 13756-13761.
19. Klumpp, M., Scheel, A., Lopez-Calle, E., Busch, M., Murray, K. J., and Pope, A. J. (2001) Ligand binding to transmembrane receptors on intact cells or membrane vesicles measured in a homogeneous 1-microliter assay format, J. Biomol. Screen. 6, 159-170.
20. Rudiger, M., Haupts, U., Moore, K. J., and Pope, A. J. (2001) Single-molecule detection technologies in miniaturized high throughput screening: binding assays for g protein-coupled receptors using fluorescence intensity distribution analysis and fluorescence anisotropy, J. Biomol. Screen. 6, 29-37.
21. Scheel, A. A., Funsch, B., Busch, M., Gradl, G., Pschorr, J., and Lohse, M. J. (2001) Receptor-ligand interactions studied with homogeneous fluorescence-based assays suitable for miniaturized screening, J. Biomol. Screen. 6, 11-18.
22. Schenk, A., Ivanchenko, S., Rocker, C., Wiedenmann, J., and Nienhaus, G. U. (2004) Photodynamics of red fluorescent proteins studied by fluorescence correlation spectroscopy, Biophys. J. 86, 384-394.
23. Auer, M., Moore, K. J., Meyer-Almes, F. J., Guenther, R., Pope, A. J., and Stoeckli, K. (1998) Fluorescence correlation spectroscopy: lead discovery by miniaturized HTS, Drug Discov. Today 3, 457-465.
24. Zemanova, L., Schenk, A., Valler, M. J., Nienhaus, G. U., and Heilker, R. (2003) Confocal optics microscopy for biochemical and cellular high-throughput screening, Drug Discov. Today 8, 1085-1093.
25. Eggeling, C., Brand, L., Ullmann, D., and Jager, S. (2003) Highly sensitive fluorescence detection technology currently available for HTS, Drug Discov. Today 8, 632-641.
26. Maguire, J. J., Kuc, R. E., Rous, B. A., and Davenport, A. P. (1996) Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments, Br. J. Pharmacol. 118, 335-342.
27. Hechler, U., Becker, A., Haendler, B., and Schleuning, W. D. (1993) Stable expression of human endothelin receptors ETA and ETB by transfected baby hamster kidney cells, Biochem. Biophys. Res. Commun. 194, 1305-1310.
28. Davenport, A. P. (1997) Distribution of endothelin receptors, in Endothelin in Biology and Medicine (Mille, R., Pelton, J. T., and Huggins, J., Eds.) pp 45-68, CRC Press, Boca Raton, FL.
29. Himeno, A., Shigematsu, K., Taguchi, T., and Niwa, M. (1998) Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: interaction in the recognition of endothelin-1 between ETA and ETB receptors, Cell Mol. Neurobiol. 18, 447-452.
30. Harada, N., Himeno, A., Shigematsu, K., Sumikawa, K., and Niwa, M. (2002) Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer, Cell Mol. Neurobiol. 22, 207-226.
31. Hay, D. W., and Luttmann, M. A. (1997) Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists, J. Pharmacol. Exp. Ther. 280, 959-965.
32. Henry, P. J., and King, S. H. (1999) Typical endothelin ETA receptors mediate atypical endothelin-1-induced contractions in sheep-isolated tracheal smooth muscle, J. Pharmacol. Exp. Ther. 289, 1385-1390.
33. Cain, M. J., Garlick, R. K., and Sweetman, P. M. (1991) Endothelin-1 receptor binding assay for high throughput chemical screening J. Cardiovasc. Pharmacol. 17 Suppl 7, S150-S151.
34. Raschack, M., Unger, L., Riechers, H., and Klinge, D. (1995) Receptor selectivity of endothelin antagonists and prevention of vasoconstriction and endothelin-induced sudden death, J. Cardiovasc. Pharmacol. 26 Suppl 3, S397-S399.
35. Nambi, P., Pullen, M., Wu, H. L., Lee, D., Saunders, D., Heys, R., Aiyar, N., Leber, J., Elliott, J., Brooks, D., Ohlstein, E., and Ruffolo, R. (1996) Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors, J. Pharmacol. Exp. Ther. 277, 1567-1571.
36. Servitja, J. M., Masgrau, R., Sarri, E., and Picatoste, F. (1998) Involvement of ET(A) and ET(B) receptors in the activation of phospholipase D by endothelins in cultured rat cortical astrocytes, Br. J. Pharmacol. 124, 1728-1734.
37. Desmarets, J., and Frelin, C. (1999) High affinity interaction of endothelin-3 with recombinant ETA receptors, Biochem. Biophys. Res. Commun. 256, 357-360.
38. Chan, M. F., Okun, I., Stavros, F. L., Hwang, E., Wolff, M. E., and Balaji, V. N. (1994) Identification of a new class of ETA selective endothelin antagonists by pharmacophore directed screening, Biochem. Biophys. Res. Commun. 201, 228-234.